#mckessonideashare
©2024 McKesson Corporation. All rights reserved.
Continuous glucose monitors (CGMs) have revolutionized diabetes care and are now being explored for broader clinical applications. This session will highlight the clinical utility of CGMs, strategies for interpreting CGM data, and advancements in CGM technology that extend their benefits beyond diabetes management. Join us to enhance your understanding of CGM devices and learn how to counsel patients on maximizing their use for improved health outcomes.
1. Explain the role of CGMs in both diabetes management and broader clinical care.
2. Interpret CGM data to identify trends and inform patient care decisions.
3. Describe strategies for counseling patients on the correct use and maintenance of CGMs.
4. Evaluate recent advancements in CGM technology and their implications for patient care.
5. Demonstrate knowledge of CGM data interpretation in a case scenario to optimize patient outcomes.
Technician Learning Objectives
1. Define the key features and functions of CGM devices used in patient care.
2. Describe the basic process for setting up and troubleshooting CGM devices.
3. Explain common patient questions related to CGM device usage and maintenance.
4. Outline the role of pharmacy technicians in supporting CGM-related services.
5. Demonstrate how to troubleshoot CGM sensor placement and device setup under pharmacist supervision.
Meet Your Speaker
Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education
University of South Carolina College of Pharmacy
Jennifer N. Clements, is a Clinical Professor and Director of Pharmacy Education with the University of South Carolina College of Pharmacy at the School of Medicine – Greenville Campus. Dr. Clements earned her Pharm.D. from Campbell University in 2006 and completed a primary care pharmacy practice residency in 2007 at the Ralph H. Johnson VA Medical Center in Charleston, South Carolina. She began her academic career in 2007 and developed pharmacy practice sites in a VA Medical Center and rural-health family medicine clinic with focus on chronic disease state management, specifically diabetes and obesity. From 2019 to 2022, Dr. Clements provided medication management for people with diabetes within an interprofessional practice model in a 1000+ bed healthcare system and chaired the health system’s Diabetes Advisory Council. She has authored numerous publications and presentations related to diabetes and obesity pharmacotherapy. Dr. Clements is an active member of the American Association of Clinical Endocrinology, American Diabetes Association, Association of Diabetes Care and Education Specialists, American Society of Health-System Pharmacists, and American College of Clinical Pharmacy. She is a board-certified pharmacotherapy specialist, ambulatory care pharmacist, and advanced diabetes manager, as well as holding certification in diabetes care and education.
Jennifer Clements discloses that she is a member of the speaker bureau for Novo Nordisk and Eli Lilly. All relevant financial relationships have been mitigated.
Financial support for this course was provided through an educational grant from McKesson Health Mart.
Pharmacist Universal Activity Number (UAN): 0107-0000-25-090-L01-P
Technician Universal Activity Number (UAN): 0107-0000-25-090-L01-T
Application-based activity
CPE Redemption:
To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), learners must participate in the course and complete the exam* and evaluation. Shortly after both the exam and evaluation are successfully completed and submitted, the CPE Statement of Credit can be accessed on CPE Monitor at www.MyCPEMonitor.net.
*CEimpact provides two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.